
RECOMBINANT HUMAN TUMOR NECROSIS FACTOR RECEPTOR Fc FUSION PROTEIN(TNFR:Fc) THERAPY IN KIDNEY TRANSPLANT RECIPIENTS RECEIVING OKT3 INDUCTION THERAPY
Author(s) -
Erik J. Novak,
Consuelo M. Blosch,
John P. Perkins,
Connie L. Davis,
Darlene Barr,
John P. McVicar,
Rachael S. Griffin,
Allen L. Farrand,
Mark H. Wener,
Christopher L. Marsh
Publication year - 1998
Publication title -
transplantation
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-199805131-00292
Subject(s) - medicine , azathioprine , creatinine , kidney , kidney transplantation , gastroenterology , monoclonal antibody , acute tubular necrosis , methylprednisolone , cytokine , tumor necrosis factor alpha , transplantation , immunology , antibody , disease